Troglitazone induces differentiation in Trypanosoma brucei

Exp Cell Res. 2007 May 15;313(9):1805-19. doi: 10.1016/j.yexcr.2007.03.003. Epub 2007 Mar 15.

Abstract

Trypanosoma brucei, a protozoan parasite causing sleeping sickness, is transmitted by the tsetse fly and undergoes a complex lifecycle including several defined stages within the insect vector and its mammalian host. In the latter, differentiation from the long slender to the short stumpy form is induced by a yet unknown factor of trypanosomal origin. Here we describe that some thiazolidinediones are also able to induce differentiation. In higher eukaryotes, thiazolidinediones are involved in metabolism and differentiation processes mainly by binding to the intracellular receptor peroxisome proliferator activated receptor gamma. Our studies focus on the effects of troglitazone on bloodstream form trypanosomes. Differentiation was monitored using mitochondrial markers (membrane potential, succinate dehydrogenase activity, inhibition of oxygen uptake by KCN, amount of cytochrome transcripts), morphological changes (Transmission EM and light microscopy), and transformation experiments (loss of the Variant Surface Glycoprotein coat and increase of dihydroliponamide dehydrogenase activity). To further investigate the mechanisms responsible for these changes, microarray analyses were performed, showing an upregulation of expression site associated gene 8 (ESAG8), a potential differentiation regulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Cell Differentiation / drug effects*
  • Cell Differentiation / physiology
  • Cell Respiration / drug effects*
  • Cell Respiration / physiology
  • Cell Shape / drug effects
  • Cell Shape / physiology
  • Chromans / pharmacology*
  • Cytochromes / genetics
  • Cytochromes / metabolism
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology
  • Gene Expression Regulation / physiology
  • Hypoglycemic Agents / pharmacology
  • Membrane Glycoproteins / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potential, Mitochondrial / physiology
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Oxygen Consumption / drug effects
  • Oxygen Consumption / physiology
  • Protozoan Proteins / genetics
  • Succinate Dehydrogenase / drug effects
  • Succinate Dehydrogenase / metabolism
  • Thiazolidinediones / pharmacology*
  • Troglitazone
  • Trypanosoma brucei brucei / drug effects*
  • Trypanosoma brucei brucei / metabolism*
  • Trypanosoma brucei brucei / ultrastructure
  • Trypanosomiasis, African / drug therapy
  • Up-Regulation / genetics

Substances

  • Biomarkers
  • Chromans
  • Cytochromes
  • Hypoglycemic Agents
  • Membrane Glycoproteins
  • Protozoan Proteins
  • Thiazolidinediones
  • ESAG 8 protein, Trypanosoma brucei
  • Succinate Dehydrogenase
  • Troglitazone